OR WAIT null SECS
May 06, 2010
The biotechnology markets in the United States, Europe, and Canada, and Australia reached aggregate profitability in 2009, according to Ernst & Young.
FDA Approves AstraZeneca's and Pozen's Vimovo; Merck Announces Management Changes; And More.
May 02, 2010
FDA wants industry to talk to them about the science underlying process innovations-really.
Chemocatalysis and biocatalysis are important elements of an effective strategy for improving yield and stereoselectivty.
The growth of Brazil's generic-drug market is on a fast track, but what are the projections for the sector's future?
A Pharma Business Imperative.
When vessels, seals, and cooling units go haywire, operators must get in the mix.
May 01, 2010
A Technical Forum featuring representatives from Dow Chemical, ISP, and DMV-Fonterra Excipients. This article is part of PharmTech's supplement "Solid Dosage and Excipients 2010."
The author describes the new IPEA excipient good-manufacturing-practice certification program that is now ANSI accredited. This article is part of a special issue on excipients and solid dosage.
The authors review new regulatory expectations and describe potential approaches to accommodate excipient variability. This article is part of PharmTech's supplement "Solid Dosage and Excipients 2010."